Ensysce Biosciences Buy Hold or Sell Recommendation
| ENSCWDelisted Stock | USD 0.01 0.0008 8.16% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Ensysce Biosciences is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Ensysce Biosciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Ensysce Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note, we conduct extensive research on individual companies such as Ensysce and provide practical buy, sell, or hold advice based on investors' constraints. Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Ensysce |
Execute Ensysce Biosciences Buy or Sell Advice
The Ensysce recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ensysce Biosciences. Macroaxis does not own or have any residual interests in Ensysce Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ensysce Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Ensysce Biosciences Trading Alerts and Improvement Suggestions
| Ensysce Biosciences is not yet fully synchronised with the market data | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ensysce Biosciences generates negative cash flow from operations |
Ensysce Biosciences Returns Distribution Density
The distribution of Ensysce Biosciences' historical returns is an attempt to chart the uncertainty of Ensysce Biosciences' future price movements. The chart of the probability distribution of Ensysce Biosciences daily returns describes the distribution of returns around its average expected value. We use Ensysce Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ensysce Biosciences returns is essential to provide solid investment advice for Ensysce Biosciences.
| Mean Return | 8.97 | Value At Risk | -47.33 | Potential Upside | 85.33 | Standard Deviation | 50.45 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ensysce Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ensysce Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ensysce . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.29 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 0.0084 | |||
| Day Typical Price | 0.0086 | |||
| Market Facilitation Index | 0.0028 | |||
| Price Action Indicator | 2.0E-4 | |||
| Period Momentum Indicator | (0.0008) | |||
| Relative Strength Index | 50.43 |
About Ensysce Biosciences Buy or Sell Advice
When is the right time to buy or sell Ensysce Biosciences? Buying financial instruments such as Ensysce Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ensysce Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy ETFs Thematic Idea Now
Energy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 91 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |